And just had the privilege of having an alive section in Brazil from the IASLC Awardee Lectureship Leah Backhus MD MPH FACS at Connect 2024. I call this privillege 🤩🤩🤩

New health disparity data in #JTCVS: National enrollment of #lungcancer clinical trials is disproportionate based on race and health care access. Read more from Case Western Reserve: doi.org/10.1016/j.jtcv…

Why hasn’t transplantation for lung cancer taken off? Ankit Bharat, MD FACS from Northwestern Medicine says it’s due to data showing low survival rates. However, Dr. Bharat says patients may still benefit from the approach. #MechSummit2024

Caros colegas, no dia 22 de Novembro o GBOT é o Oncoguia irão realizar um evento dedicado às mulheres que têm ou tiveram diagnóstico de câncer de pulmão. Informem.suas pacientes. Venha participar se for paciente!

The IASLC #Reviewer Workshop is a one-day workshop at #WCLC25, led by journal editors to train early and mid-career IASLC members in manuscript review. Applications open on January 24 to members in Europe. More information at: bit.ly/ReviewerWS #LCSM JTO & JTO CRR

Science today faces a profound crisis. In my new book, I draw upon personal experience to propose evidence-based, actionable solutions to pressing issues in research funding, publishing, incentives, and administration. Available on Amazon in hardcover, paperback, and Kindle

✨  Honored to be nominated for a seat on the IASLC Board of Directors! It’s an exciting opportunity to help shape the future of  #LungCancer  research and care. I’d be truly grateful for your support and your vote. 🙏 iaslc.org/2025-board-dir…

A few years ago Linda Martin gave a a talk at AATS that you can't imagine to do things if don't see people like you doing the same. Such an incredible talk Dr Chang from New York University that clarifies a bunch of things to me for the future. Congrats Dr Chang!

Federico Raveglia and Alessandro Bertani proudly represented ESTS at the 2025 STS/EACTS/ESTS Latin America Thoracic Surgery Conference in Recife | TÓRAX 2025. A strong showing of global collaboration in thoracic surgery. 🌍🫁 #ESTS #TORAX2025 #ThoracicSurgery #STS #EACTS

Do we need to change the SoC Ttx for Pancoast NSCLC🫁? Cohort of cases treated: induction CTIO —>Surgery. pCR 100%, strong prognostic marker in these rare 🫁.We discuss challenges to apply this approach in daily practice. High expertise surgery needed authors.elsevier.com/sd/article/S20…

77% of patients with unresectable stage 3 #lungcancer converted to resectable & had R0 with good outcome This underlines importance of refining our definitions of resectability & also that we need to keep an open mind about the “potentially resectable” group #WCLC2025

“Resectability depends on a state of mind” - Matthias Guckenberger …and society perspectives #WCLC25

Congratulations Dr Law for this excellent presentation and Eric Lim & final proof of reduction of overall risk of death (21%!) of VATS in comparison to Open surgery! What’s next ? Robotic 🦾even more ❓🙋‍♀️

So grateful to be with women thoracic surgeons who are friends, collaborators, and supporters — learning from each other and advancing the fight against lung cancer together! #WCLC25 IASLC WomenInThoracicSurg

Powerful talk by Maria Teresa Tsukazan Schwarz at #WCLC25: ‘You Need to Be in the OR. No, You Need to Be at the Playground.’ Grateful she highlighted our study with Cecilia Pompili MD PhD FACS on return after parental leave in thoracic surgery, an issue deeply impacting equity in our field.

Come to our session, starting in 20 minutes! Oligometastatic dilemmas - we will discuss a variety of cutting edge questions in this space. #WCLC25 #LCSM WomenInThoracicSurg

Hypoxemia on VV #ECMO?? Develop a systematic approach 🚧 quickly rule out (with circuit check + blood gas analysis) things killing the patient rapidly but that you can quickly troubleshoot: extreme recirculation, ML failure and gas supply interruption, drainage insufficiency

Clinicians can enhance patient understanding by using numerical data instead of verbal probabilities, consistent denominators, absolute risk comparisons, and clear context for unfamiliar data types. ja.ma/42JRNGk